ED
AGN

Exane Derivatives’s Allergan Inc AGN Stock Holding History

Exane Derivatives’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-423
Closed -$89.9K – 586
2014
Q4 		$89.9K Buy
+423
New +$84.1K 0.01% 294

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Exane Derivatives's AGN Position: Q1 2015 in Review

Exane Derivatives sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 423 shares — an estimated $89.9K sold.

Exane Derivatives first reported a position in AGN in Q4 2014 and held it in 1 quarter. The position peaked at $89.9K in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Exane Derivatives reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Exane Derivatives sold 423 Allergan Inc shares in Q1 2015, an estimated $89.9K.
  • Exane Derivatives first reported a position in Allergan Inc in Q4 2014 and held it in 1 quarter.
  • Exane Derivatives's Allergan Inc position peaked at $89.9K in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Exane Derivatives's 13F filing for Q1 2015, filed 15 May 2015.